Publicacións nas que colabora con Anxo Fernández Ferreiro (74)
2024
-
Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics
International Journal of Pharmaceutics, Vol. 662
-
Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab
Pharmaceuticals, Vol. 17, Núm. 2
-
The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration
Pharmaceutics, Vol. 16, Núm. 1
-
Towards Precision Medicine in Clinical Practice: Alinity C vs. UHPLC-MS/MS in Plasma Aripiprazole Determination
Pharmaceutics, Vol. 16, Núm. 1
-
Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling
Psychiatry Research, Vol. 333
2023
-
Ampicillin Stability in a Portable Elastomeric Infusion Pump: A Step Forward in Outpatient Parenteral Antimicrobial Therapy
Pharmaceutics, Vol. 15, Núm. 8
-
Antifungal Combination Eye Drops for Fungal Keratitis Treatment
Pharmaceutics, Vol. 15, Núm. 1
-
Correction: A Review of Population Pharmacokinetic Analyses of Linezolid (Clinical Pharmacokinetics, (2022), 61, 6, (789-817), 10.1007/s40262-022-01125-2)
Clinical Pharmacokinetics
-
Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence
Pharmaceutics, Vol. 15, Núm. 11
-
Design and biopharmaceutical preclinical characterisation of a new thermosensitive hydrogel for the removal of gastric polyps
International Journal of Pharmaceutics, Vol. 635, pp. 122706
-
Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial
Pharmaceutics, Vol. 15, Núm. 2
-
Enhancing Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Comparative Analysis of Rapid Point-of-Care Infliximab, Adalimumab and Anti-Drug Antibodies’ Determination against ELISA
Pharmaceutics, Vol. 15, Núm. 11
-
Estudio farmacocinético de adalimumab intravítreo en un modelo de rata con uveítis mediante PET
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
-
Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration
Investigative ophthalmology & visual science, Vol. 64, Núm. 13, pp. 34
-
NEmecum: digital tool for assisting in the prescription and dispensing of enteral nutrition formulas and infant preparations
Nutricion Hospitalaria, Vol. 40, Núm. 5, pp. 924-933
-
Perspectives of Therapeutic Drug Monitoring of Biological Agents in Non-Infectious Uveitis Treatment: A Review
Pharmaceutics, Vol. 15, Núm. 3
2022
-
A Review of Population Pharmacokinetic Analyses of Linezolid
Clinical Pharmacokinetics, Vol. 61, Núm. 6, pp. 789-817
-
Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence
Pharmaceutics, Vol. 14, Núm. 10
-
Effects of Loigolactobacillus coryniformis K8 CECT 5711 on the Immune Response of Elderly Subjects to COVID-19 Vaccination: A Randomized Controlled Trial
Nutrients, Vol. 14, Núm. 1
-
Elaboración de medicamentos personalizada en los Servicios de Farmacia Hospitalaria: ¿Quo vadis?
Revista de la OFIL, Vol. 32, Núm. 1, pp. 87-88